Authors’ Reply to Nicolas: “Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”

Detalles Bibliográficos
Autores principales: Concordet, Didier, Gandia, Peggy, Montastruc, Jean-Louis, Bousquet-Mélou, Alain, Lees, Peter, Ferran, Aude A., Toutain, Pierre-Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007421/
https://www.ncbi.nlm.nih.gov/pubmed/31802398
http://dx.doi.org/10.1007/s40262-019-00851-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007421/
https://www.ncbi.nlm.nih.gov/pubmed/31802398
http://dx.doi.org/10.1007/s40262-019-00851-4

Ejemplares similares